FUNCTIONAL COPPER SULFIDE COMPOSITION AND A FUNCTIONAL FIBER PRODUCED THEREFROM

    公开(公告)号:US20180066384A1

    公开(公告)日:2018-03-08

    申请号:US15561485

    申请日:2016-03-22

    Abstract: The present invention relates to a functional copper sulfide composition and a functional fiber prepared therefrom, and more particularly, a functional copper sulfide composition comprising a copper salt, a metal salt, a reducing agent, a sulfur compound, a catalyst, a polyvalent amine, an alkali compound and a pH adjusting agent; and a functional fiber prepared by treating the composition with a fiber.The present invention can provide a functional fiber with excellent conductivity, washing resistance, washability, durability, moisture resistance and alkali resistance, wherein the color of the fiber is maintained even when it is washed repeatedly or used for a long time.In addition, the present invention can provide a functional fiber which has excellent an antibacterial, deodorant, far-infrared radiation, wound healing, skin aging prevention, insulation, electromagnetic shielding and static electricity removal characteristics, and can be widely used in clothing, industrial and military field such as clothing, socks, gloves, bands, abdominal binder, masks, hats, bandage, scarf, bedclothes, burn pad, a hospital gown, an industrial filter and filler.

    METHOD FOR DIAGNOSING GLIOMA AND SCREENING FOR THE THERAPEUTICS OF GLIOMA THROUGH IDENTIFYING PROTEIN RELOCATION
    2.
    发明申请
    METHOD FOR DIAGNOSING GLIOMA AND SCREENING FOR THE THERAPEUTICS OF GLIOMA THROUGH IDENTIFYING PROTEIN RELOCATION 有权
    通过鉴定蛋白质转移来诊断GLIOMA和GLIOMA治疗方法

    公开(公告)号:US20140106376A1

    公开(公告)日:2014-04-17

    申请号:US14059283

    申请日:2013-10-21

    CPC classification number: G01N33/6893 G01N33/57407 G01N2500/00

    Abstract: The present invention relates to a method for diagnosing glioma by comparing the protein location of an individual to be diagnosed with the normal control nerve cells. More particularly, the present invention relates to a method for diagnosing glioma including determining that an individual has glioma when the expression level of GFRα4 in the endoplasmic reticulum is higher than that in the plasma membrane, and a method for screening a therapeutic agent for glioma. In the diagnostic method of the present invention, the protein expression levels in particular subcellular locations are compared, thereby accurately diagnosing glioma, diagnosing progression of glioma, and predicting prognosis after glioma surgery.

    Abstract translation: 本发明涉及通过比较待诊断个体与正常对照神经细胞的蛋白质位置来诊断胶质瘤的方法。 更具体地,本发明涉及当内质网中GFRα4的表达水平高于质膜时的神经胶质瘤诊断方法,包括确定个体具有神经胶质瘤,以及用于筛选胶质瘤治疗剂的方法。 在本发明的诊断方法中,比较特定亚细胞位置的蛋白质表达水平,从而精确诊断神经胶质瘤,诊断胶质瘤的进展,并预测胶质瘤手术后的预后。

Patent Agency Ranking